Luminex Molecular Diagnostics xTAG Respiratory Viral Panel (RVP): Box Label: xTAG RVP (Respiratory Viral Panel). Catalogue Number:I019C0111 in vitro diagnostic test Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
xTAG Respiratory Viral Panel (RVP): Box Label: xTAG RVP (Respiratory Viral Panel). Catalogue Number:I019C0111 in vitro diagnostic test
Brand
Luminex Molecular Diagnostics
Lot Codes / Batch Numbers
Not specified in FDA notice. Check official source for details.
Products Sold
Catalogue Number:I019C0111 Device UDI: 00840487100462 Lot Numbers: IK019C-0129 IK019C-0130 IK019C-0131 IK019C-0132
Luminex Molecular Diagnostics is recalling xTAG Respiratory Viral Panel (RVP): Box Label: xTAG RVP (Respiratory Viral Panel). Catalogue Numbe due to The Assay may give a false negative result when detecting and subtyping Influenza A (H3) and detecting RSV A in patient specimens. However, the assay . Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
The Assay may give a false negative result when detecting and subtyping Influenza A (H3) and detecting RSV A in patient specimens. However, the assay will continue to detect Influenza A, Influenza B, RSV B and all other targets in accordance with each of these products performance claims.
Recommended Action
Per FDA guidance
An initial Customer Advisory Notice was sent to customers on Jul/16/2019 to advise customers of the firm's potential concerns of false negative results while the firm is conducting its recall investigation. On August 8, 2019, the firm sent to customers via email an "URGENT: MEDICAL DEVICE RECALL/FIELD CORRECTION" Letter to customer which informed its customers of the potential concerns of false negative results and provided them with two options for handling the affected products. The recall letter provided customers with the following options: Option 1: 1. Segregate Recalled Product. Please immediately remove all affects lots from their inventory that are unused and unexpired (regardless of location) and segregate these lots in a secure location for destruction. 2. Complete Acknowledgment and Receipt Form 1. Complete and return the enclosed Acknowledgment and Receipt Form 1 by email (support@luminexcorp.com) or mail (even if you do not have any product on hand), following the directions on this page and the Acknowledgment and Receipt Form. Global Support Services can assist customers in completing the form, if needed. Please destroy the product and provide confirmation in the Acknowledgment and Receipt Form on or before July xx, 2019. The firm will replace any unused products and handle any customer concerns on a case-by-case basis. Please inform Global Support Services if you destroyed product and need a replacement(s). Option 2: If customer have the affected products and wish to continue using the product for testing, customers are instructed to complete Acknowledgment and Receipt Form 2 which states that customer acknowledged that they will continue using the affected product and will not use the product for testing and reporting results for the Influenza A (H3) and RSV A. Customers are instructed to complete and return the enclosed Acknowledgment and Receipt Form 2 by email (support@luminexcorp.com) or mail, following the directions on t
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
CA, CT, MA, PA
Page updated: Jan 10, 2026